Ribbon Acquisition Corp. held an Extraordinary General Meeting on September 10, 2026, where shareholders approved eight proposals including the business combination with DRC Medicine Ltd., domestication as a Delaware corporation, and charter amendments to remove net tangible asset redemption restrictions. Approximately 3.43 million shares were redeemed for $36.3 million at $10.59 per share, leaving approximately $1.4 million in the trust account. The company operates in the special purpose acquisition company (SPAC) industry.

Ribbon Acquisition Corp. deposited $125,000 into its public shareholders' trust account to extend the deadline to complete its initial business combination by one month, moving the date from July 15, 2026, to August 15, 2026. The company is a special purpose acquisition company (SPAC) formed to effect a business combination.